Your browser doesn't support javascript.
loading
Treatment of obesity type 1 diabetes with Dapagliflozin:a case report / 中国糖尿病杂志
Chinese Journal of Diabetes ; (12): 133-136, 2024.
Article de Zh | WPRIM | ID: wpr-1025162
Bibliothèque responsable: WPRO
ABSTRACT
As a new hypoglycemic drug,Dapagliflozin has attracted much attention because of its unique hypoglycemic mechanism. It has been used in many studies on type 2 diabetes mellitus,but the application of type 1 diabetes mellitus(T1DM)in the eastern population is rare. This article uses Dapagliflozin through a case of obese T1DM to provide new ideas for the treatment of T1DM.
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Chinese Journal of Diabetes Année: 2024 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: Chinese Journal of Diabetes Année: 2024 Type: Article